Delcath Systems DCTH Stock
Delcath Systems Price Chart
Delcath Systems DCTH Financial and Trading Overview
| Delcath Systems stock price | 4.95 USD |
| Previous Close | 6.69 USD |
| Open | 6.75 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 4000 |
| Day's Range | 6.68 - 6.98 USD |
| 52 Week Range | 2.34 - 7.99 USD |
| Volume | 33.59K USD |
| Avg. Volume | 55.94K USD |
| Market Cap | 71.05M USD |
| Beta (5Y Monthly) | 0.847183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.94 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.4 USD |
DCTH Valuation Measures
| Enterprise Value | 74.93M USD |
| Trailing P/E | N/A |
| Forward P/E | -5.309524 |
| PEG Ratio (5 yr expected) | -0.19 |
| Price/Sales (ttm) | 24.18419 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 25.505 |
| Enterprise Value/EBITDA | -2.223 |
Trading Information
Delcath Systems Stock Price History
| Beta (5Y Monthly) | 0.847183 |
| 52-Week Change | 84.80% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.99 USD |
| 52 Week Low | 2.34 USD |
| 50-Day Moving Average | 6.38 USD |
| 200-Day Moving Average | 4.43 USD |
DCTH Share Statistics
| Avg. Volume (3 month) | 55.94K USD |
| Avg. Daily Volume (10-Days) | 38.22K USD |
| Shares Outstanding | 10.62M |
| Float | 10.32M |
| Short Ratio | 9.35 |
| % Held by Insiders | 2.87% |
| % Held by Institutions | 13.06% |
| Shares Short | 480.88K |
| Short % of Float | 5.12% |
| Short % of Shares Outstanding | 4.53% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:700 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1151.73% |
| Gross Margin | 71.61% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -73.031% |
| Return on Equity (ttm) | -694.26% |
Income Statement
| Revenue (ttm) | 2.94M USD |
| Revenue Per Share (ttm) | 0.3 USD |
| Quarterly Revenue Growth (yoy) | 57.89% |
| Gross Profit (ttm) | 2.03M USD |
| EBITDA | -33707000 USD |
| Net Income Avi to Common (ttm) | -36508000 USD |
| Diluted EPS (ttm) | -3.67 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.22M USD |
| Total Cash Per Share (mrq) | 2.28 USD |
| Total Debt (mrq) | 9.73M USD |
| Total Debt/Equity (mrq) | 183.94 USD |
| Current Ratio (mrq) | 2.164 |
| Book Value Per Share (mrq) | -1.297 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22839000 USD |
| Levered Free Cash Flow (ttm) | -6374750 USD |
Profile of Delcath Systems
| Country | United States |
| State | NY |
| City | New York |
| Address | 1633 Broadway |
| ZIP | 10019 |
| Phone | 212 489 2100 |
| Website | https://www.delcath.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 52 |
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
Q&A For Delcath Systems Stock
What is a current DCTH stock price?
Delcath Systems DCTH stock price today per share is 4.95 USD.
How to purchase Delcath Systems stock?
You can buy DCTH shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Delcath Systems?
The stock symbol or ticker of Delcath Systems is DCTH.
Which industry does the Delcath Systems company belong to?
The Delcath Systems industry is Medical Devices.
How many shares does Delcath Systems have in circulation?
The max supply of Delcath Systems shares is 25.44M.
What is Delcath Systems Price to Earnings Ratio (PE Ratio)?
Delcath Systems PE Ratio is now.
What was Delcath Systems earnings per share over the trailing 12 months (TTM)?
Delcath Systems EPS is -2.94 USD over the trailing 12 months.
Which sector does the Delcath Systems company belong to?
The Delcath Systems sector is Healthcare.
Delcath Systems DCTH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}